{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:51:26Z","timestamp":1758959486014},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T00:00:00Z","timestamp":1416182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-829","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T04:01:04Z","timestamp":1416196864000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Bo-lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrius","family":"Baskys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,17]]},"reference":[{"key":"5008_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1634\/theoncologist.11-3-252","volume":"11","author":"D Pectasides","year":"2006","unstructured":"Pectasides D, Pectasides M, Economopoulos T: Brain metastases from epithelial ovarian cancer: a review of the literature. Oncologist. 2006, 11: 252-260. 10.1634\/theoncologist.11-3-252.","journal-title":"Oncologist"},{"key":"5008_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/gyno.1993.1082","volume":"49","author":"M Bruzzone","year":"1993","unstructured":"Bruzzone M, Campora E, Chiara S, Giudici S, Merlini L, Simoni C, Mammoliti S, Rubagotti A, Rosso R: Cerebral metastases secondary to ovarian cancer: still an unusual event. Gynecol Oncol. 1993, 49: 37-40. 10.1006\/gyno.1993.1082.","journal-title":"Gynecol Oncol"},{"key":"5008_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1006\/gyno.1995.1134","volume":"57","author":"JP Geisler","year":"1995","unstructured":"Geisler JP, Geisler HE: Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol. 1995, 57: 246-249. 10.1006\/gyno.1995.1134.","journal-title":"Gynecol Oncol"},{"key":"5008_CR4","first-page":"2793","volume":"29","author":"K Pietzner","year":"2009","unstructured":"Pietzner K, Oskay-Oezcelik G, El Khalfaoui K, Boehmer D, Lichtenegger W, Sehouli J: Brain metastases from epithelial ovarian cancer: overview and optimal management. Anticancer Res. 2009, 29: 2793-2798.","journal-title":"Anticancer Res"},{"key":"5008_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1385\/BTER:74:3:223","volume":"74","author":"K Namikawa","year":"2000","unstructured":"Namikawa K, Asakura M, Minami T, Okazaki Y, Kadota E, Hashimoto S: Toxicity of cisplatin to the central nervous system of male rabbits. Biol Trace Elem Res. 2000, 74: 223-235. 10.1385\/BTER:74:3:223.","journal-title":"Biol Trace Elem Res"},{"key":"5008_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ygyno.2004.05.026","volume":"94","author":"B Melichar","year":"2004","unstructured":"Melichar B, Urminska H, Kohlova T, Nova M, Cesak T: Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature. Gynecol Oncol. 2004, 94: 267-276. 10.1016\/j.ygyno.2004.05.026.","journal-title":"Gynecol Oncol"},{"key":"5008_CR7","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/annonc\/mdq229","volume":"21","author":"J Sehouli","year":"2010","unstructured":"Sehouli J, Pietzner K, Harter P, Munstedt K, Mahner S, Hasenburg A, Camara O, Wimberger P, Boehmer D, Buehling KJ, Richter R, El Khalfaoui K, Oskay-Ozcelik G: Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol. 2010, 21: 2201-2205. 10.1093\/annonc\/mdq229.","journal-title":"Ann Oncol"},{"key":"5008_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1006\/gyno.2002.6653","volume":"85","author":"N Anupol","year":"2002","unstructured":"Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S: Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol. 2002, 85: 487-492. 10.1006\/gyno.2002.6653.","journal-title":"Gynecol Oncol"},{"key":"5008_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/B:NEON.0000014516.04943.38","volume":"66","author":"ZR Cohen","year":"2004","unstructured":"Cohen ZR, Suki D, Weinberg JS, Marmor E, Lang FF, Gershenson DM, Sawaya R: Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol. 2004, 66: 313-325.","journal-title":"J Neurooncol"},{"key":"5008_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1525-1438.2003.13054.x","volume":"13","author":"G Cormio","year":"2003","unstructured":"Cormio G, Rossi C, Cazzolla A, Resta L, Loverro G, Greco P, Selvaggi L: Distant metastases in ovarian carcinoma. Int J Gynecol Cancer. 2003, 13: 125-129. 10.1046\/j.1525-1438.2003.13054.x.","journal-title":"Int J Gynecol Cancer"},{"key":"5008_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1525-1438.2007.00941.x","volume":"17","author":"TJ Kim","year":"2007","unstructured":"Kim TJ, Song S, Kim CK, Kim WY, Choi CH, Lee JH, Lee JW, Bae DS, Kim BG: Prognostic factors associated with brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer. 2007, 17: 1252-1257. 10.1111\/j.1525-1438.2007.00941.x.","journal-title":"Int J Gynecol Cancer"},{"key":"5008_CR12","first-page":"3553","volume":"25","author":"D Pectasides","year":"2005","unstructured":"Pectasides D, Aravantinos G, Fountzilas G, Kalofonos C, Efstathiou E, Karina M, Pavlidis N, Farmakis D, Economopoulos T, Dimopoulos MA: Brain metastases from epithelial ovarian cancer. the Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature. Anticancer Res. 2005, 25: 3553-3558.","journal-title":"Anticancer Res"},{"key":"5008_CR13","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1182\/blood.V90.12.5013","volume":"90","author":"S Miraglia","year":"1997","unstructured":"Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997, 90: 5013-5021.","journal-title":"Blood"},{"key":"5008_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/onc.2008.374","volume":"28","author":"T Baba","year":"2009","unstructured":"Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK: Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. 2009, 28: 209-218. 10.1038\/onc.2008.374.","journal-title":"Oncogene"},{"key":"5008_CR15","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R: CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 2009, 27: 2875-2883.","journal-title":"Stem Cells"},{"key":"5008_CR16","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008, 68: 4311-4320. 10.1158\/0008-5472.CAN-08-0364.","journal-title":"Cancer Res"},{"key":"5008_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/modpathol.2011.170","volume":"25","author":"J Zhang","year":"2012","unstructured":"Zhang J, Guo X, Chang DY, Rosen DG, Mercado-Uribe I, Liu J: CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol. 2012, 25: 456-464. 10.1038\/modpathol.2011.170.","journal-title":"Mod Pathol"},{"key":"5008_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ctrv.2009.03.002","volume":"35","author":"JX Cheng","year":"2009","unstructured":"Cheng JX, Liu BL, Zhang X: How powerful is CD133 as a cancer stem cell marker in brain tumors?. Cancer Treat Rev. 2009, 35: 403-408. 10.1016\/j.ctrv.2009.03.002.","journal-title":"Cancer Treat Rev"},{"key":"5008_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/1471-2407-9-221","volume":"9","author":"G Ferrandina","year":"2009","unstructured":"Ferrandina G, Martinelli E, Petrillo M, Prisco MG, Zannoni G, Sioletic S, Scambia G: CD133 antigen expression in ovarian cancer. BMC Cancer. 2009, 9: 221-10.1186\/1471-2407-9-221.","journal-title":"BMC Cancer"},{"key":"5008_CR20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1248\/bpb.33.738","volume":"33","author":"Y Liao","year":"2010","unstructured":"Liao Y, Hu X, Huang X, He C: Quantitative analyses of CD133 expression facilitate researches on tumor stem cells. Biol Pharm Bull. 2010, 33: 738-742. 10.1248\/bpb.33.738.","journal-title":"Biol Pharm Bull"},{"key":"5008_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1158\/1078-0432.CCR-07-0932","volume":"14","author":"F Zeppernick","year":"2008","unstructured":"Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC: Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res. 2008, 14: 123-129. 10.1158\/1078-0432.CCR-07-0932.","journal-title":"Clin Cancer Res"},{"key":"5008_CR22","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002, 20: 1248-1259. 10.1200\/JCO.20.5.1248.","journal-title":"J Clin Oncol"},{"key":"5008_CR23","volume-title":"Cochrane Database Syst Rev","author":"A Elattar","year":"2011","unstructured":"Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R: Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2011, 10: CD007565"},{"key":"5008_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2283","volume":"214","author":"D Mizrak","year":"2008","unstructured":"Mizrak D, Brittan M, Alison M: CD133: molecule of the moment. J Pathol. 2008, 214: 3-9. 10.1002\/path.2283.","journal-title":"J Pathol"},{"key":"5008_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1741-7015-10-85","volume":"10","author":"SS Zhang","year":"2012","unstructured":"Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, Wang H, Wang Y, Li R, Yang Y, Zhao X, Xu XD, Yu ED, Rui YC, Liu HJ, Zhang L, Wei LX: CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med. 2012, 10: 85-10.1186\/1741-7015-10-85.","journal-title":"BMC Med"},{"key":"5008_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007, 1: 313-323. 10.1016\/j.stem.2007.06.002.","journal-title":"Cell Stem Cell"},{"key":"5008_CR27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3892\/or.2014.3245","volume":"32","author":"K Chen","year":"2014","unstructured":"Chen K, Li Z, Jiang P, Zhang X, Zhang Y, Jiang Y, He Y, Li X: Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma. Oncol Rep. 2014, 32: 755-763.","journal-title":"Oncol Rep"},{"key":"5008_CR28","first-page":"2111","volume":"118","author":"SV Shmelkov","year":"2008","unstructured":"Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008, 118: 2111-2120.","journal-title":"J Clin Invest"},{"key":"5008_CR29","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/stem.711","volume":"29","author":"B Choijamts","year":"2011","unstructured":"Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M: CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Mullerian tumor). Stem Cells. 2011, 29: 1485-1495. 10.1002\/stem.711.","journal-title":"Stem Cells"},{"key":"5008_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajog.2006.10.874","volume":"196","author":"E Bignotti","year":"2007","unstructured":"Bignotti E, Tassi RA, Calza S, Ravaggi A, Bandiera E, Rossi E, Donzelli C, Pasinetti B, Pecorelli S, Santin AD: Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol. 2007, 196: 245-e241-211","journal-title":"Am J Obstet Gynecol"},{"key":"5008_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1476-4598-13-223","volume":"13","author":"L Alonso-Alconada","year":"2014","unstructured":"Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D, Coenegrachts L, Cano A, Gil-Moreno A, Chiva L, Cueva J, Vieito M, Ortega E, Mariscal J, Colas E, Castellvi J, Cusido M, Dolcet X, Nijman HW, Bosse T, Green JA, Romano A, Reventos J, Lopez-Lopez R, Salvesen HB, Amant F, Matias-Guiu X, Moreno-Bueno G, et al: Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer. 2014, 13: 223-10.1186\/1476-4598-13-223.","journal-title":"Mol Cancer"},{"key":"5008_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","volume":"119","author":"S Pakneshan","year":"2014","unstructured":"Pakneshan S, Safarpour D, Tavassoli F, Jabbari B: Brain metastasis from ovarian cancer: a systematic review. J Neurooncol. 2014, 119: 1-6. 10.1007\/s11060-014-1447-9.","journal-title":"J Neurooncol"},{"key":"5008_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3171\/jns.1992.76.3.0444","volume":"76","author":"JR Adler","year":"1992","unstructured":"Adler JR, Cox RS, Kaplan I, Martin DP: Stereotactic radiosurgical treatment of brain metastases. J Neurosurg. 1992, 76: 444-449. 10.3171\/jns.1992.76.3.0444.","journal-title":"J Neurosurg"},{"key":"5008_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jnci\/87.1.34","volume":"87","author":"E Alexander 3rd","year":"1995","unstructured":"Alexander E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995, 87: 34-40. 10.1093\/jnci\/87.1.34.","journal-title":"J Natl Cancer Inst"},{"key":"5008_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ygyno.2007.11.027","volume":"108","author":"YK Lee","year":"2008","unstructured":"Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP: Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol. 2008, 108: 505-509. 10.1016\/j.ygyno.2007.11.027.","journal-title":"Gynecol Oncol"},{"key":"5008_CR36","doi-asserted-by":"publisher","first-page":"e94476","DOI":"10.1371\/journal.pone.0094476","volume":"9","author":"AS Brodsky","year":"2014","unstructured":"Brodsky AS, Fischer A, Miller DH, Vang S, MacLaughlan S, Wu HT, Yu J, Steinhoff M, Collins C, Smith PJ, Raphael BJ, Brard L: Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease. PLoS One. 2014, 9: e94476-10.1371\/journal.pone.0094476.","journal-title":"PLoS One"},{"key":"5008_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1101\/gr.108803.110","volume":"21","author":"N Matsumura","year":"2011","unstructured":"Matsumura N, Huang Z, Mori S, Baba T, Fujii S, Konishi I, Iversen ES, Berchuck A, Murphy SK: Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer. Genome Res. 2011, 21: 74-82. 10.1101\/gr.108803.110.","journal-title":"Genome Res"},{"key":"5008_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ijc.25961","volume":"130","author":"S Yamamura","year":"2012","unstructured":"Yamamura S, Matsumura N, Mandai M, Huang Z, Oura T, Baba T, Hamanishi J, Yamaguchi K, Kang HS, Okamoto T, Abiko K, Mori S, Murphy SK, Konishi I: The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int J Cancer. 2012, 130: 20-28. 10.1002\/ijc.25961.","journal-title":"Int J Cancer"},{"key":"5008_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbrc.2007.06.070","volume":"360","author":"T Baba","year":"2007","unstructured":"Baba T, Mori S, Matsumura N, Kariya M, Murphy SK, Kondoh E, Kusakari T, Kuroda H, Mandai M, Higuchi T, Takakura K, Fukuda MN, Fujii S: Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity. Biochem Biophys Res Commun. 2007, 360: 363-369. 10.1016\/j.bbrc.2007.06.070.","journal-title":"Biochem Biophys Res Commun"},{"key":"5008_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.clim.2011.08.013","volume":"141","author":"J Hamanishi","year":"2011","unstructured":"Hamanishi J, Mandai M, Abiko K, Matsumura N, Baba T, Yoshioka Y, Kosaka K, Konishi I: The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors. Clin Immunol. 2011, 141: 338-347. 10.1016\/j.clim.2011.08.013.","journal-title":"Clin Immunol"},{"key":"5008_CR41","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1158\/1078-0432.CCR-12-2199","volume":"19","author":"K Abiko","year":"2013","unstructured":"Abiko K, Mandai M, Hamanishi J, Yoshioka Y, Matsumura N, Baba T, Yamaguchi K, Murakami R, Yamamoto A, Kharma B, Kosaka K, Konishi I: PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction. Clin Cancer Res. 2013, 19: 1363-1374. 10.1158\/1078-0432.CCR-12-2199.","journal-title":"Clin Cancer Res"},{"key":"5008_CR42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ygyno.2009.11.020","volume":"116","author":"JC Barnett","year":"2010","unstructured":"Barnett JC, Bean SM, Whitaker RS, Kondoh E, Baba T, Fujii S, Marks JR, Dressman HK, Murphy SK, Berchuck A: Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Gynecol Oncol. 2010, 116: 556-562. 10.1016\/j.ygyno.2009.11.020.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-829\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T17:08:16Z","timestamp":1650647296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,17]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-829","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,17]]},"assertion":[{"value":"9 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"829"}}